JP2009514525A5 - - Google Patents

Download PDF

Info

Publication number
JP2009514525A5
JP2009514525A5 JP2008538854A JP2008538854A JP2009514525A5 JP 2009514525 A5 JP2009514525 A5 JP 2009514525A5 JP 2008538854 A JP2008538854 A JP 2008538854A JP 2008538854 A JP2008538854 A JP 2008538854A JP 2009514525 A5 JP2009514525 A5 JP 2009514525A5
Authority
JP
Japan
Prior art keywords
klh
adjuvant
immunogenic
immunostimulatory
furoyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008538854A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009514525A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/040215 external-priority patent/WO2007055682A2/en
Publication of JP2009514525A publication Critical patent/JP2009514525A/ja
Publication of JP2009514525A5 publication Critical patent/JP2009514525A5/ja
Pending legal-status Critical Current

Links

JP2008538854A 2005-11-07 2005-11-07 修飾された免疫刺激性ジヌクレオチドを含む、オリゴヌクレオチドに基づく化合物の免疫刺激特性 Pending JP2009514525A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/040215 WO2007055682A2 (en) 2005-11-07 2005-11-07 Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011227910A Division JP2012051921A (ja) 2011-10-17 2011-10-17 修飾された免疫刺激性ジヌクレオチドを含む、オリゴヌクレオチドに基づく化合物の免疫刺激特性

Publications (2)

Publication Number Publication Date
JP2009514525A JP2009514525A (ja) 2009-04-09
JP2009514525A5 true JP2009514525A5 (cg-RX-API-DMAC7.html) 2011-12-08

Family

ID=38023708

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008538854A Pending JP2009514525A (ja) 2005-11-07 2005-11-07 修飾された免疫刺激性ジヌクレオチドを含む、オリゴヌクレオチドに基づく化合物の免疫刺激特性

Country Status (7)

Country Link
EP (1) EP1945653A4 (cg-RX-API-DMAC7.html)
JP (1) JP2009514525A (cg-RX-API-DMAC7.html)
CN (1) CN101351469A (cg-RX-API-DMAC7.html)
AU (1) AU2005338050B2 (cg-RX-API-DMAC7.html)
CA (1) CA2630118A1 (cg-RX-API-DMAC7.html)
MX (1) MX2008006004A (cg-RX-API-DMAC7.html)
WO (1) WO2007055682A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US7276489B2 (en) * 2002-10-24 2007-10-02 Idera Pharmaceuticals, Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
US7354907B2 (en) * 2003-02-07 2008-04-08 Idera Pharmaceuticals, Inc. Short immunomodulatory oligonucleotides
US7470674B2 (en) * 2005-11-07 2008-12-30 Idera Pharmaceuticals, Inc. Immunostimulatory properties of oligonucleotide-based compounds comprising modified immunostimulatory dinucleotides
AU2015269412B2 (en) 2014-06-04 2020-03-12 Exicure Operating Company Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
WO2016081911A2 (en) 2014-11-21 2016-05-26 Northwestern University The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
CA3023451A1 (en) 2016-05-06 2017-11-09 Exicure, Inc. Liposomal spherical nucleic acid (sna) constructs presenting antisense oligonucleotides (aso) for specific knockdown of interleukin 17 receptor mrna
WO2018039629A2 (en) 2016-08-25 2018-03-01 Northwestern University Micellar spherical nucleic acids from thermoresponsive, traceless templates
WO2018201090A1 (en) 2017-04-28 2018-11-01 Exicure, Inc. Synthesis of spherical nucleic acids using lipophilic moieties
WO2018209270A1 (en) 2017-05-11 2018-11-15 Northwestern University Adoptive cell therapy using spherical nucleic acids (snas)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785610B2 (en) * 2001-06-21 2010-08-31 Dynavax Technologies Corporation Chimeric immunomodulatory compounds and methods of using the same—III
WO2003035836A2 (en) * 2001-10-24 2003-05-01 Hybridon Inc. Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends
JP4726630B2 (ja) * 2003-01-16 2011-07-20 イデラ ファーマシューティカルズ インコーポレイテッド 修飾された免疫賦活性ジヌクレオチドを用いることによるオリゴヌクレオチドに基づく化合物の免疫賦活特性の調節
KR101138131B1 (ko) * 2003-12-08 2012-04-23 이데라 파마슈티칼즈, 인코포레이티드 작은 올리고뉴클레오티드-기초 화합물에 의한 면역자극특성의 조절

Similar Documents

Publication Publication Date Title
CO6382137A2 (es) Oligonucleótidos inmunoestimuladores
WO2009010877A3 (en) Conjugate purification
ATE383872T1 (de) Ein immunostimulierendes nukleotid und ein tocol enthaltende zusammensetzung
DK1959992T3 (da) Immunogen sammensætning indeholdende en adjuvans.
LU91778I2 (fr) Menveo - vaccin méningococcique des groupes A,C, W135 et Y conjugué.
IL186701A0 (en) C. perfringens alpha toxoid vaccine
TW200643028A (en) Vaccine
PE20071058A1 (es) Vacuna de streptococcus pneumoniae
GB0428394D0 (en) Saccharide conjugate vaccines
EA201391788A1 (ru) Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
BR112012002603A2 (pt) composição imunogênica, proteína de fusão, polinucleotídeo, vacina, processo para preparar a vacina, uso da composição imunogênica, e, método para tratar ou prevenir doença estafilocócica.
EP2601969A3 (en) Norovirus vaccine formulations
DE60015084D1 (de) Verbesserung der bakterizidaktivität von neisseria antigenen mit cg enthaltende oligonukleotiden
DK1898948T3 (da) Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
CA2763359C (en) New human rotavirus strains and vaccines
WO2006113372A3 (en) Porcine circovirus and helicobacter combination vaccines
JP2009514527A5 (cg-RX-API-DMAC7.html)
EP1829887A4 (en) CPG single-stranded desoxynucleotides for use as ADJUVANS
FR2922767B1 (fr) Procede de preparation d'une composition vaccinale comprenant au moins un antigene et au moins un adjuvant.
DK1112747T3 (da) Salmonellavaccine, som ikke inducerer antistoffer mod flagellin eller flageller
WO2007082105A3 (en) Chlamydia vaccine
WO2007038122A3 (en) Immunogenic capsule composition for use as a vaccine component against campylobacter jejuni
GB2444676A (en) Adjuvanted vaccine
WO2005021033A3 (en) Vaccine
WO2001022994A3 (en) Vaccines against neisseria infection